ET Auto.com – Report on 1,338 patents filed by India-domiciled cos in US in 2018-19

Indian firms file 1,338 patents in chemistry, AI domains in 2018-19: Report: New Delhi: Over 1,300 patents were filed by India firms in the US in 2018-19 across domains like pharmaceuticals, artificial intelligence, chemistry, and communication technology, a report by industry body Nasscom said.

A total of 1,338 patents were filed in 2018-19, of which 59.4 percent were tech patents with computer technology, communication technology, and AI being the top domain areas, the report said.

It added that IT services companies like Tata Consultancy Services, Infosys, Wipro and HCL were among the top filers. The report is based on data extracted from the Questel Orbit Patent Database as on January 31, 2020, with the support of Sagacious IP.

It noted that 2018-19 data is provisional data, considering there is a window of approximately 18 months from the filing date to the publication date.

Thus some of the patent applications filed for 2018 and 2019 may not have been published (disclosed in the public domain) yet, it added. The provisional number for 2017-18 was 1,287.

Among the non-tech patents (40.6 percent) in 2018-19, the top domain areas were chemistry and chemical compositions, pharmaceuticals, and mechanical and structural inventions.

The top filers included Reliance Industries Ltd, Sun Pharma, Welspun, and Hindustan Petroleum Corporation Ltd. The report said AI continues to lead in terms of total patents filed under emerging technology, while cloud computing patents led in terms of growth.

It added that Indian startups filed over 280 technology patents during 2015-2019 with maximum patents being filed in the area of healthcare and medical devices.

Also, new-age application areas such as logistics, text/data mining, gaming, consumer electronics, and vehicle technology led the technology patent growth story.

Originally published on: https://auto.economictimes.indiatimes.com/news/industry/1338-patents-filed-by-india-domiciled-cos-in-us-in-2018-19-report/75398212

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

Exclusive Webinar Series
Exclusive Webinar Series. Cost: $0 (Free) Limited Seats Available. Don't miss the opportunity, Register Now